FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23636011000001109: Vipidia 12.5mg tablets (Takeda UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77137901000001112 Vipidia 12.5mg tablets (Takeda UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77138001000001114 Vipidia 12.5mg tablets (Takeda UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vipidia 12.5mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Is a Alogliptin 12.5mg tablets true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Is a Vipidia true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has specific active ingredient Alogliptin benzoate false Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin false Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has specific active ingredient Alogliptin benzoate true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Alogliptin true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has active ingredient Alogliptin true Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Vipidia 12.5mg tablets (Takeda UK Ltd) Has basis of strength substance Alogliptin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Vipidia 12.5mg tablets (Takeda UK Ltd) 28 tablet 2 x 14 tablets Has AMP True Vipidia 12.5mg tablets (Takeda UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start